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lettersWe select the letters for these pages from the rapid responses posted on bmj.com favouring those received within five days of publication of the article to which they 
refer. Letters are thus an early selection of rapid responses 
on a particular topic. Readers should consult the website 
for the full list of responses and any authors’ replies, which 
usually arrive after our selection.
ManageMent of haeMorrhoids
Symptoms govern treatment
Acheson and Scholefield reviewed the 
management of haemorrhoids.1 At our centre, 
we have adopted an approach whereby 
symptoms govern the therapeutic decision.
For many patients, bleeding is the principal 
symptom, and we have used Doppler guided 
haemorrhoidal artery ligation (DGHAL) since 
2004 in those whose condition has not improved 
after injection of oily phenol in the outpatient 
clinic. Over this time we have treated more than 
400 patients. In 113 with long term follow-up, 
the rate of symptoms recurring was 19% at 30 
months and the rate of complications low.
Although this technique has proved effective 
in the control of bleeding, it is not effective in 
the treatment of prolapsed haemorrhoids, with 
recurrence of prolapse occurring in 64% at 30 
months. Many patients experience prolapse 
of their piles, which can lead to discharge of 
mucus, pruritus, and occasionally seepage of 
stool. Contrary to the cover of the BMJ, Acheson 
and Scholefield did not highlight the most 
recent advance in haemorrhoidal treatment.
Modification of the DGHAL transducer has 
allowed for the undertaking of DGHAL together 
with rectoanal repair (RAR). This technique was 
introduced at our unit in January 2007 to treat 
symptomatic prolapsed haemorrhoids. We 
have treated 92 patients with a symptomatic 
relief rate of 82% at three months. Although the 
inclusion of a RAR makes this a more painful 
procedure than DGHAL, patient satisfaction is 
high. More recently we have been undertaking 
DGHAL with or without RAR under conscious 
sedation, using midazolam and remifentanil. 
Altogether 48% of patients were entirely pain 
free during the procedure, with the remaining 
52% having a median pain score of 3 out of 
10. It is therefore possible to obtain pain free 
symptomatic relief of bleeding or prolapsed 
haemorrhoids in the day surgical setting.
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long terM outcoMe of stroke
Stroke is a chronic disease with 
acute events
Bruins et al and the accompanying editorial 
on stroke care make a compelling case for 
reviewing conventional policy approaches to 
stroke, which often show a dysequilibrium 
towards the (very important) front end of stroke, 
and a relative agnosia for (equally important) 
aftercare.1 Although it is clearly very important 
that all should have access to stroke unit care 
(and thrombolysis for those for whom it is 
indicated), most patients will still have residual 
disability after both of these interventions and 
will be more prone to further strokes than the 
rest of the population. Comprehensive national 
audits of stroke care show alarming levels of 
neglect in terms of chronic disease management 
and seem to indicate a collective nihilism about 
the potential for altering function and wellbeing 
after the early treatment of stroke,2 despite 
evidence of the effectiveness of continuing 
therapy and support at long intervals after 
stroke.3 We need to ensure that the potential 
for altering functional status and wellbeing 
is maximised at six months (and beyond). 
Highlighting the chronic disease aspect of stroke 
care may best serve this aspiration by promoting 
a timely focus on prevention, care, and 
support needs through patient education and 
empowerment,4 as well as the development of 
models of care which bring together primary and 
secondary care.5 This may require a reorientation 
of practice and training for stroke physicians, 
which do not currently emphasise the chronic 
course of the illness, or models of chronic 
disease management, which promote the role of 
the patient as partner.
Desmond o’Neill principal investigator des.oneill@amnch.ie 
Frances horgan senior lecturer 
anne hickey senior lecturer 
hannah McGee principal investigator, Irish National Audit of 
Stroke Care, Royal College of Surgeons in Ireland, Dublin 2, 
Republic of Ireland
competing interests: None declared.
Bruins Slot K, Berge E, Dorman P, Lewis S, Dennis M, 1 
Sandercock P, on behalf of the Oxfordshire Community 
Stroke Project, the International Stroke Trial (UK), and 
the Lothian Stroke Register Collaborative Groups. 
Impact of functional status at six months on long term 
survival in patients with ischaemic stroke: prospective 
cohort studies. BMJ 2008;336:376-9. (16 February.)
Horgan F, Hickey A, Murphy S, Wiley M, Conroy R, 2 
McGee H, et al. First Irish national audit of stroke care. 
Cerebrovasc Dis 2007;23(suppl 2):132.
Ouellette MM, LeBrasseur NK, Bean JF, Phillips E, Stein 3 
J, Frontera WR, et al. High-intensity resistance training 
improves muscle strength, self-reported function, 
and disability in long-term stroke survivors. Stroke 
2004;35:1404-9.
Jones F. Strategies to enhance chronic disease self-4 
management: how can we apply this to stroke? Disabil 
Rehabil 2006;28:841-7.
Allen KR, Hazelett S, Jarjoura D, Wickstrom GC, Hua K, 5 
Weinhardt J, et al. Effectiveness of a postdischarge care 
management model for stroke and transient ischemic 
attack: a randomised trial. J Stroke Cerebrovasc Dis 
2002;11:88-98.
follow-up after breast cancer
National randomised controlled 
trial is needed
Dixon and Montgomery recommend that 
breast cancer follow-up be evidence 
based, flexible, and tailored to patients’ 
needs.1 Unfortunately neither their proposal 
to provide only annual clinical review for 
two years nor the 2002 guideline from the 
National Institute for Health and Clinical 
Excellence, which recommends hospital based 
follow-up for no longer than three years for 
asymptomatic patients, is evidence based. A 
recent Cochrane review showed a wide range 
of recommendations for follow-up practice 
and identified the urgent need for a large 
randomised controlled trial to assess the 
optimum model of care.2 A key question in the 
debate is the rationale for follow-up. A recent 
survey of 256 breast surgeons and oncologists 
showed that follow-up was principally aimed 
at managing treatment related morbidity 
(93%), alongside detecting new abnormalities 
(82%), psychological morbidity (81%), and 
recurrences (80%).3 Dixon and Montgomery’s 
optimism that (outside the guidance provided 
by the Quality and Outcomes Framework) 
timely intervention by primary care doctors 
will reduce anxiety or that assessment by 
note review should identify need for input 
at the time of mammography is not shared 
by colleagues who expressed concern about 
